Prism Medico and Pharmacy Share Price

28.000.61 (2.22%)

BSE

Closed
As On:
As On: 22 Jun, 2026, 03:40 PM IST

Sector: Trading
Industry: Trading

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-28.00
Previous Day	-27.39

Prism Medico Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Prism Medico Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018
Total Income	9.78	6.62	8.71	16.75	17.13
Total Income Growth (%)	47.61	-23.96	-48.01	-2.22	13.76
Total Expenses	9.75	6.47	8.63	17.55	16.96
Total Expenses Growth (%)	50.67	-25.01	-50.83	3.51	14.93
EBIT	0.03	0.15	0.08	-0.80	0.18
EBIT Growth (%)	-82.84	89.38	-	-555.69	-42.71
Profit after Tax (PAT)	-0.04	0.09	0.13	-0.70	0.15
PAT Growth (%)	-147.33	-27.85	-	-578.31	-46.97
EBIT Margin (%)	0.27	2.29	0.92	-4.78	1.02
Net Profit Margin (%)	-0.45	1.42	1.49	-4.20	0.86
Basic EPS (₹)	-0.07	0.15	0.21	0.00	0.24

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	0.28	0.08	0.52	1.59	0.08
Total Income Growth (%)	263.93	-84.99	-67.34	1,798.57	-60.54
Total Expenses	0.41	0.09	0.60	0.94	0.06
Total Expenses Growth (%)	345.88	-84.84	-35.95	1,469.23	-72.95
EBIT	-0.12	-0.01	-0.08	0.65	0.02
EBIT Growth (%)	-	-	-112.60	2,622.59	-
Profit after Tax (PAT)	-0.24	-0.01	-0.08	0.66	0.04
PAT Growth (%)	-	-	-112.90	1,483.86	-
EBIT Margin (%)	-43.28	-16.94	-15.80	40.95	28.55
Net Profit Margin (%)	-84.94	-17.20	-16.34	41.36	49.58
Basic EPS (₹)	-0.30	-0.02	-0.14	0.01	0.07

	FY 2019	FY 2018
Total Revenue	54.72	22.84
Total Revenue Growth (%)	139.55	327.17
Total Expenses	54.82	22.78
Total Expenses Growth (%)	140.69	309.62
Profit after Tax (PAT)	0.04	0.00
PAT Growth (%)	-	-
Operating Profit Margin (%)	0.01	1.56
Net Profit Margin (%)	0.07	-0.01
Basic EPS (₹)	0.07	-0.01

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2.47	0.65	3.05	1.27	8.44
Total Revenue Growth (%)	280.86	-78.72	139.54	-84.93	-49.63
Total Expenses	2.04	0.71	3.08	1.37	8.94
Total Expenses Growth (%)	185.62	-76.78	123.74	-84.63	-47.20
Profit after Tax (PAT)	0.32	-0.05	-0.02	-0.08	-0.37
PAT Growth (%)	-	-	-	-	-
Operating Profit Margin (%)	17.71	-10.14	-0.71	-8.02	-5.90
Net Profit Margin (%)	13.03	-7.70	-0.73	-6.01	-4.38
Basic EPS (₹)	0.53	-0.08	-0.05	-0.13	-0.61

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 280.86% outperformed its 3 year CAGR of 24.47%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 2.47% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

View Details

Balance Sheet

Annual	FY 2019	FY 2018
Total Assets	21.20	15.80
Total Assets Growth (%)	34.21	-8.48
Total Liabilities	8.29	2.93
Total Liabilities Growth (%)	183.23	-33.26
Total Equity	12.91	12.87
Total Equity Growth (%)	0.31	-0.03
Current Ratio (x)	1.31	1.35
Total Debt to Equity (x)	0.18	0.17
Contingent Liabilities	-	4.54

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	15.61	15.56	15.24	15.39	12.57
Total Assets Growth (%)	0.32	2.10	-0.97	22.43	-41.64
Total Liabilities	0.20	0.47	0.10	0.23	0.02
Total Liabilities Growth (%)	-57.45	370.00	-56.52	1,050.00	-99.77
Total Equity	15.41	15.09	15.14	15.16	12.55
Total Equity Growth (%)	2.12	-0.33	-0.13	20.80	-2.94
Current Ratio (x)	77.34	32.43	147.53	65.34	708.22
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	-	-	-	-

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)

View Details

Cash Flows

Annual	FY 2019	FY 2018
Net Cash flow from Operating Activities	-0.44	3.55
Net Cash used in Investing Activities	-	-2.53
Net Cash flow from Financing Activities	-0.50	-1.61
Net Cash Flow	-0.94	-0.59
Closing Cash & Cash Equivalent	0.41	1.36
Closing Cash & Cash Equivalent Growth (%)	-69.58	-
Total Debt/ CFO (x)	-5.16	0.61

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	0.00	-0.02	-0.01	2.95	-2.38
Net Cash used in Investing Activities	-	-	-	-2.91	2.35
Net Cash flow from Financing Activities	0.00	0.00	-0.01	-3,254.00	-4,602.40
Net Cash Flow	0.00	-0.02	-0.01	0.04	-0.03
Closing Cash & Cash Equivalent	0.06	0.07	0.08	0.10	0.06
Closing Cash & Cash Equivalent Growth (%)	-2.60	-21.77	-12.68	73.74	-34.51
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2019	FY 2018
Return on Equity (%)	0.31	-0.03
Return on Capital Employed (%)	0.08	2.74
Return on Assets (%)	0.18	-0.02
Interest Coverage Ratio (x)	3.67	2.78
Asset Turnover Ratio (x)	2.94	1.38
Price to Earnings (x)	588.24	-5,000.00
Price to Book (x)	1.74	1.12
EV/EBITDA (x)	61.76	19.02
EBITDA Margin (%)	0.72	3.52

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	2.06	-0.32	-0.14	-0.50	-2.94
Return on Capital Employed (%)	2.80	-0.42	-0.13	-0.67	-3.97
Return on Assets (%)	2.03	-0.31	-0.14	-0.49	-2.94
Interest Coverage Ratio (x)	132.24	-35.24	-2.20	-293.14	-1,064.32
Asset Turnover Ratio (x)	0.16	0.04	0.19	0.09	0.50
Price to Earnings (x)	48.08	-147.06	-833.33	-227.27	-12.50
Price to Book (x)	0.99	0.47	1.09	1.15	0.37
EV/EBITDA (x)	34.88	-117.54	-1,054.96	-180.98	-9.32
EBITDA Margin (%)	17.86	-9.47	-0.53	-7.50	-5.80

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Prism Medico	119.31	2.46	2.06	2.80	2.03	24.47	17.71	13.03	0.53	77.34	0.00	0.00
IFL Enterprises	-13.95	0.41	-2.96	-2.93	-1.67	96.49	-5.16	-5.16	-0.03	2.33	0.01	-0.04
CCL Intnl	49.54	0.98	1.96	5.87	1.31	45.33	5.93	1.88	0.49	2.46	0.40	2.27
Kiduja India	17.86	-1.86	-10.39	-40.38	19.55	0.00	90.95	23.66	0.93	0.35	-1.52	0.66
Jyotirgamya Enterp	-761.51	12.79	-1.34	-1.15	-0.82	-74.91	0.00	0.00	-0.18	0.17	0.14	-4.41
Add More

Annual Ratios (%)

Choose from Peers

Chandra Prabhu
Nirav Comm
Franklin Industries
Mayukh Dealtrade
NMS Resources Global

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Prism Medico Stock Performance	2.22	-6.07	-9.85	24.00	73.05	-12.09	146.48
IFL Enterprises Stock Performance	2.50	0.00	-14.58	-12.77	-49.38	-96.29	0.00
CCL Intnl Stock Performance	-0.68	-0.57	-9.63	1.74	-14.04	-15.28	45.40
Kiduja India Stock Performance	4.67	-14.97	1.04	0.00	-14.93	175.42	0.00
Jyotirgamya Enterp Stock Performance	0.00	0.00	0.00	0.00	36.43	0.00	0.00
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	15,45,861	25.49 %	0.48
Pledge	0	0.00 %	0.00
Others	45,17,567	74.51 %	-0.48

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	25.49	25.00	25.00	25.00
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	74.51	75.00	75.00	75.00

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 25, 2026
General Meeting
-
Feb 25, 2026
Board Meeting
Quarterly Results
Feb 09, 2026

Board Meetings

Announced on	Meeting on
May 25, 2026	May 28, 2026
Audited Results
Feb 09, 2026	Feb 13, 2026
Quarterly Results
Nov 06, 2025	Nov 14, 2025
Quarterly Results
Sep 01, 2025	Sep 05, 2025
Others
Aug 07, 2025	Aug 14, 2025
Quarterly Results

Dividends
No Data Available
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Feb 25, 2026 Mar 20, 2026
-
Sep 15, 2025 Sep 30, 2025
-
Sep 16, 2024 Sep 30, 2024
A.G.M.
Sep 14, 2023 Sep 30, 2023
A.G.M.
Jul 20, 2023 Aug 14, 2023
-

Announced on	Meeting on
Feb 25, 2026	Mar 20, 2026
-
Sep 15, 2025	Sep 30, 2025
-
Sep 16, 2024	Sep 30, 2024
A.G.M.
Sep 14, 2023	Sep 30, 2023
A.G.M.
Jul 20, 2023	Aug 14, 2023
-

About Prism Medico

Prism Medico and Pharmacy Ltd., incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 37.98 Crore) operating in Trading sector.

Prism Medico and Pharmacy Ltd. key Products/Revenue Segments include Agriculture Products for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs .28 Crore, up 263.93 % from last quarter Total Income of Rs .08 Crore and up 238.71 % from last year same quarter Total Income of Rs .08 Crore. Company has reported net profit after tax of Rs -.24 Crore in latest quarter.

The company’s top management includes Ms.Sakshi Laller, Mrs.Dinesh Kumar, Mr.Pardeep Kumar, Mr.Davender Singh, Mr.Bharat Singh, Mr.Sameer Gupta. Company has Garg Mendiratta & Associates as its auditors. As on 31-03-2026, the company has a total of .61 Crore shares outstanding.

Prism Medico Share Price Today is Rs. 28.00. On previous day, the Prism Medico Share Price (NSE) closed at Rs. 26.99, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 25.49% of the stake in Prism Medico shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Prism Medico stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Prism Medico shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Prism Medico stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Prism Medico Dividend: Ever since 2002, Prism Medico dividends has been paid out around 0 times. As on 22 Jun, 2026, 03:40 PM IST, The overall dividend yield for Prism Medico stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 0.23.

Prism Medico Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 0.28 Cr. of sales and 263.93% of quarterly net profit, there have been multiple ups and downs in the Prism Medico stock prices in the past few weeks. For example, Prism Medico stock price on 12th of June 2026 was around Rs. 28.4. Prism Medico share price now stands at an average of Rs. 28.00. Judging by last week's performance, stock is in down trend.

Prism Medico has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Prism Medico share.

Historical Prices and Performance:
Prism Medico, incorporated in 2002 is a Small Cap company (with a market cap of Rs. 37.15) operating in Trading sector.
The Return of Equity (ROE) in last five financial years given by Prism Medico stock was 2.06%, -0.32%, -0.14%, -0.5% and -2.94% respectively.
The Prism Medico share gave a 3 year return of 5.47% as compared to Nifty 50 which gave a return of 28.03%.
Prism Medico announced 0.0% final dividend on null.

Key Metrics:
PE Ratio of Prism Medico is 116.71
Prices/Sales Ratio of Prism Medico is 6.26
Price/Book Ratio of Prism Medico is 2.41

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 116.71 and 2.41 respectively.

Leadership of Prism Medico :
Bharat Singh is Chief Financial Officer
Sameer Gupta is Company Secretary
Sakshi Laller is Whole Time Director
Davender Singh is Director
Pardeep Kumar is Independent Director
Dinesh Kumar is Independent Director

Industry

Trading

Key Indices Listed On

-

Address

Suketi Road,Kala Amb,Sirmour, Himachal Pradesh - 173030

Contact

investorgrievancewmcl@gmail.com

www.prismmedico.in

PE Ratio(x)	119.31
EPS - TTM(₹)	0.23
MCap(₹ Cr.)	37.98
MCap Rank	61
PB Ratio(x)	2.41
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	34.49
52W Low(₹)	12.49
MCap/Sales	6.26
Beta(1 Month)	-0.18
BV/Share(₹)	11.36

1 Day	2.22%
1 Month	-7.59%
3 Months	7.53%
1 Year	90.74%
3 Years	12.0%
5 Years	236.94%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Prism Medico and Pharmacy Share Price

Key Metrics

Prism Medico share price insights

Prism Medico Share Price Returns

Prism Medico Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Prism Medico Top Searches

Corporate Actions

About Prism Medico

Executive Leadership

Auditors

FAQs about Prism Medico share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News